Univest
Univest
  • Markets

Fortis Healthcare Q4 FY26 Results: PAT Rs 271 Cr

  • May 25, 2026
  • Posted by: Neeraj Pandey
  • Category: News
No Comments
Fortis Healthcare Q4 FY26 Results

Fortis Healthcare Q4 FY26 results were declared on May 22, 2026. The company reported PAT of Rs 271 crore for the quarter ended March 31, 2026, up 44.1% YoY compared to Rs 188 crore in Q4 FY25. Revenue stood at Rs 2,365 crore, for the quarter ended March 31, 2026. Results are on a Consolidated basis. Fortis Healthcare is a Hospitals company listed on Indian stock exchanges.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Fortis Healthcare Q4 FY26 Financial Highlights
  • Fortis Healthcare Q4 FY26 Performance Analysis
  • Key Factors Driving Fortis Healthcare Q4 FY26 Results
    • Revenue and Business Performance
    • Profitability and Margin Trends
    • India Macro Environment Q4 FY26
    • FY27 Outlook
  • Frequently Asked Questions on the company
    • What is Fortis Healthcare Q4 FY26 net profit?
    • What is Fortis Healthcare Q4 FY26 revenue?
    • When were Fortis Healthcare Q4 FY26 results declared?
    • Is Fortis Healthcare a good investment after Q4 FY26?

Fortis Healthcare Q4 FY26 Financial Highlights

Metric Q4 FY26 (Rs Cr) Q4 FY25 (Rs Cr) YoY Change
Revenue Rs 2,365 crore Rs N/A crore N/A
Net Profit 271 188 +44.1%
Basis Consolidated

Note: Fortis Healthcare Q4 FY26 results declared May 22, 2026. Data sourced from Screener.in/BSE filings. Verify from audited filings before investment decisions.

Fortis Healthcare Q4 FY26 Performance Analysis

The Fortis Healthcare Q4 FY26 results reflect the company’s performance in the January to March 2026 quarter. The company delivered results in line with sector trends. Fortis Healthcare operates in the Hospitals segment, benefiting from India’s GDP growth above 6.5% and domestic demand conditions in FY26.

Revenue of Rs 2,365 crore was for the quarter ended March 31, 2026. Steady revenue reflects consistent business conditions.

Screen the best stocks on the Univest Screener.

Key Factors Driving Fortis Healthcare Q4 FY26 Results

Revenue and Business Performance

Revenue of Rs 2,365 crore in Fortis Healthcare Q4 FY26 was for the quarter ended March 31, 2026. Stable revenue momentum reflects consistent operational delivery. The January to March 2026 quarter is the year-end quarter for Indian companies, characterised by strong order execution and fiscal year-end activity.

Profitability and Margin Trends

The the business PAT of Rs 271 crore up 44.1% YoY. The PAT growth demonstrates improving operational leverage and business fundamentals in the Hospitals space.

India Macro Environment Q4 FY26

India’s macro environment in Q4 FY26 was supportive, with GDP growth above 6.5%, government capital expenditure of Rs 11.21 lakh crore budgeted for FY27, and resilient domestic consumption. The RBI’s accommodative stance supported credit and demand conditions. For Fortis Healthcare operating in the Hospitals sector, these macro tailwinds provided a constructive backdrop entering FY27.

FY27 Outlook

Following the firm results, management guidance on FY27 revenue trajectory, margin improvement, and capital allocation will be key investor watchpoints. The Hospitals sector continues to benefit from India’s structural growth drivers including urbanisation, infrastructure investment, and rising middle-class consumption.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Frequently Asked Questions on the company

What is Fortis Healthcare Q4 FY26 net profit?

Ans. Fortis Healthcare Q4 FY26 PAT of Rs 271 crore, up 44.1% YoY from Rs 188 crore in Q4 FY25. Results declared May 22, 2026, on a Consolidated basis. Verify from BSE/NSE filings.

What is Fortis Healthcare Q4 FY26 revenue?

Ans. Fortis Healthcare Q4 FY26 revenue was Rs 2,365 crore, for the quarter ended March 31, 2026. Verify complete financials from BSE/NSE.

When were Fortis Healthcare Q4 FY26 results declared?

Ans. Fortis Healthcare Q4 FY26 results were declared on May 22, 2026, at the board of directors meeting approving audited Q4 and FY26 financial statements.

Is Fortis Healthcare a good investment after Q4 FY26?

Ans. Investment decisions require individual assessment of fundamentals, valuation, and risk tolerance. This article is educational only. Consult a SEBI-registered financial advisor before investing.

Investments in securities are subject to market risk. This content is for educational purposes only. Verify from BSE/NSE filings. Consult a SEBI-registered financial advisor.



News Q4 Results
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply